37. Thompson, S.D., M. Larche, A.R. Manzo, and J.L. Hurwitz. 1992. Diversity of T-cell receptor alpha gene transcripts in the newborn and adult periphery. Immunogenetics. 36:95–103. 38. Mackall, C.L., C.V. Bare, L.A. Granger, S.O. Sharrow, J.A. Titus, and R.E. Gress. 1996. Thymic-independent T cell regeneration oc- curs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J. Immunol. 156:4609–4616. 39. Goronzy, J.J., and C.M. Weyand. 2003. Aging, autoimmunity and ar- thritis: T-cell senescence and contraction of T-cell repertoire diversity— catalysts of autoimmunity and chronic inflammation. Arthritis Res. Ther. 5:225–234. 40. Grabstein, K.H., C.R. Maliszewski, K. Shanebeck, T.A. Sato, M.K. Spriggs, W.C. Fanslow, and R.J. Armitage. 1993. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2. J. Immunol. 150:3141–3147. 41. Erickson, L.D., B.G. Durell, L.A. Vogel, B.P. O’Connor, M. Cas- calho, T. Yasui, H. Kikutani, and R.J. Noelle. 2002. Short-circuiting long-lived humoral immunity by the heightened engagement of CD40. J. Clin. Invest. 109:613–620. 42. Gregers, T.F., B. Fleckenstein, F. Vartdal, P. Roepstorff, O. Bakke, and I. Sandlie. 2003. MHC class II loading of high or low affinity pep- tides directed by Ii/peptide fusion constructs: implications for T cell activation. Int. Immunol. 15:1291–1299. 43. Borovsky, Z., G. Mishan-Eisenberg, E. Yaniv, and J. Rachmilewitz. 2002. Serial triggering of T cell receptors results in incremental accu- mulation of signaling intermediates. J. Biol. Chem. 277:21529–21536. 44. Ben-Sasson, S.Z., R. Gerstel, J. Hu-Li, and W.E. Paul. 2001. Cell di- vision is not a “clock” measuring acquisition of competence to pro- duce IFN-gamma or IL-4. J. Immunol. 166:112–120. 45. Weng, X., E. Priceputu, P. Chrobak, J. Poudrier, D.G. Kay, Z. Hanna, T.W. Mak, and P. Jolicoeur. 2004. CD4 T cells from CD4C/HIVNef transgenic mice show enhanced activation in vivo with impaired proliferation in vitro but are dispensable for the devel- opment of a severe AIDS-like organ disease. J. Virol. 78:5244–5257. 46. Winslow, G.M., A.D. Roberts, M.A. Blackman, and D.L. Woodland. 2003. Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse. J. Immunol. 170:2046–2052. 47. Schnittman, S.M., H.C. Lane, J. Greenhouse, J.S. Justement, M. Baseler, and A.S. Fauci. 1990. Preferential infection of CD4 memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individu- als. Proc. Natl. Acad. Sci. USA. 87:6058–6062. 48. Callan, M.F. 2003. The evolution of antigen-specific CD8 T cell re- sponses after natural primary infection of humans with Epstein-Barr virus. Viral Immunol. 16:3–16. 49. Scott, P., D. Artis, J. Uzonna, and C. Zaph. 2004. The development of effector and memory T cells in cutaneous leishmaniasis: the implica- tions for vaccine development. Immunol. Rev. 201:318–338. 50. Dunachie, S.J., and A.V. Hill. 2003. Prime-boost strategies for malaria vaccine development. J. Exp. Biol. 206:3771–3779. 1112 REPEATED STIMULATION LIMITS CD4 T CELL FUNCTION | Jelley-Gibbs et al.